Tag: Prescription Drug Plans

CVS Health, Humana to reduce Medicare Advantage operations in 2026 | Reuters

Aetna Unveils 2026 Medicare Advantage Plans with Expanded Benefits

Aetna announces its 2026 Medicare Advantage plans featuring expanded supplemental benefits, enhanced Special Needs Plans, and affordable prescription drug coverage across 43 states.

Medicare Special Enrollment Periods Offer Plan Change Opportunities After December 7 Deadline

Learn about Medicare Special Enrollment Periods and EPIC program options for switching plans after the December 7 open enrollment deadline. Understand eligibility and enrollment steps.

Kinney Drugs Partners with EnlivenHealth to Support Medicare Part D Enrollment

Kinney Drugs teams with EnlivenHealth to provide free Medicare Part D plan comparisons aiding seniors during Medicare open enrollment. Learn about plan options and enrollment strategies.

Medicare 2026: Rising Premiums and Fewer Plan Choices Impact Beneficiaries

Learn about key changes to Medicare in 2026 including rising Part B premiums, fewer Part D plans, and the impact of Medicare Advantage plan cancellations on beneficiaries. Understand market trends and enrollment advice.

Kinney Drugs Partners with EnlivenHealth to Offer Free Medicare Part D Plan Comparisons

Kinney Drugs and EnlivenHealth collaborate to assist seniors with free Medicare Part D plan comparisons during the open enrollment period ending December 7. Over 460 stand-alone PDPs and numerous Medicare Advantage plans make enrollment decisions complex.

Humana Unveils 2026 Medicare Advantage Plans Focused on Simplicity and Quality

Humana’s 2026 Medicare Advantage and Prescription Drug Plans emphasize simplicity, stability, and expanded access, with lowered premiums and enhanced benefits for Medicare beneficiaries nationwide.

Medicare Enrollment Cycles: Key Insights on Pre-AEP and AEP Periods

Gain key insights on the Medicare Annual Election Period (AEP) and Pre-AEP phases, critical for managing Medicare Advantage and Prescription Drug Plan enrollment and changes. Understand compliance, timing, and beneficiary engagement.

2025 Medicare Drug Plan Caps Lower Out-of-Pocket Costs Under Inflation Reduction Act

Starting in 2025, Medicare prescription drug plans will have a new $2,000 out-of-pocket cap under the Inflation Reduction Act, eliminating the donut hole and lowering costs for beneficiaries. This applies to both Part D and Medicare Advantage plans with drug coverage.